How did Rene Descartes' model of pain influence medicine, and why is it considered flawed today?

Descartes' 17th-century dualistic model suggested a complete separation between body and mind, with the mind passively perceiving pain generated in the body. This model influenced medical care for centuries but is now considered 'utterly and completely wrong' because pain is understood as an integrated biopsychosocial phenomenon, not merely a passive reception of signals.

What are nociceptors, and how do C-fibers and A-delta fibers differ in pain transmission?

Nociceptors are specialized transducers that convert various energy forms (pressure, heat, cold, chemical changes) into electrochemical impulses. A-delta fibers are fast and transmit sharp, well-localized pain (e.g., immediate jolt from stepping on a tack), triggering reflexes. C-fibers are slow and unmyelinated, transmitting a hot, burning, flooding sensation that serves as a longer-term 'harm alarm' to encourage healing.

Is consciousness necessary for the perception of pain during surgery?

According to Dr. Mackey, a conscious brain is necessary for the experience of pain. During surgery, patients are unconscious and do not perceive pain, although nociceptive signals (electrochemical injury signals) still reach the spinal cord and brain, triggering stress responses like cortisol surges.

What are the different categories of pain, and how do they respond to treatment?

Pain is categorized into nociceptive (from direct nociceptor activation, common in acute injuries, responds well to NSAIDs, opioids), visceral (from internal organs, diffuse, identifying specific treatments is challenging), neuropathic (from nerve injury/dysfunction, described as burning/stabbing, often treated with anti-convulsants like gabapentin), and nociplastic (central pain processing dysfunction, associated with conditions like fibromyalgia).

Can pain be objectively measured using fMRI?

Recent research, including studies by Dr. Mackey's lab, uses functional MRI (fMRI) and machine learning to identify core brain patterns representing the experience of pain. While not replacing self-report for current pain, these objective biomarkers can help predict treatment response and future pain states.

How does the Gate Control Theory of Pain explain pain modulation?

Proposed by Melzack and Wall, this theory posits that the spinal cord acts as a 'gate,' modulating incoming pain signals. Activating A-beta fibers (touch fibers, e.g., by rubbing an injured area or using a TENS unit) can send inhibitory signals to the spinal cord, reducing the pain signals that reach the brain. Brain systems, emotions, and beliefs also contribute to this descending modulation.

What role does sleep deprivation play in pain perception?

Sleep deprivation can significantly increase pain perception. It changes the set point in the brain and spinal cord for pain, impairing the prefrontal cortex's ability to modulate pain. Chronic lack of sleep can lead to a worsening cycle of pain and poor sleep.

What factors predict a higher likelihood of persistent opioid use after surgery?

Research shows that vulnerabilities like pre-operative depression, anxiety, high levels of catastrophizing, and early adverse childhood experiences (e.g., PTSD, trauma) are strong predictors of persistent pain and long-term opioid use post-surgery, due to their impact on specific brain systems.

What is fibromyalgia, and how is it characterized?

Fibromyalgia is a syndrome of widespread bodily pain (above and below the waist), associated with early morning stiffness, fatigue, mental fog, and often GI problems. It's thought to involve dysfunction in central pain processing or small fiber neuropathy, and is often preceded by traumatic events.

How does Low-Dose Naltrexone (LDN) work, and for what conditions is it used?

LDN, at 4.5 milligrams, is thought to block toll-like four receptors on microglia in the brain, reducing neuroinflammation that sensitizes central nerves. It has shown promising 'magical' effects in some patients with conditions like fibromyalgia, complex regional pain syndrome, and even some neurodegenerative conditions like multiple sclerosis, although its exact mechanism remains debated.

What is 'catastrophizing' and how does it affect pain?

Catastrophizing, a term introduced by Albert Ellis, involves three factors: amplification of pain, rumination (repetitive thoughts about pain), and a sense of helplessness. It has real neurobiologic consequences, negatively impacting prefrontal cortical circuits, impairing the brain's ability to downregulate pain, and leading to a worsening cycle.

345 ‒ Chronic pain: pathways, treatment, and the path to physical and psychological recovery

Peter Attia MD

Science & Technology6 min read196 min video

Apr 21, 2025|71,560 views|1,645|213

Peter Attia MD Dr. Peter Attia Early Medical The Drive Podcast The Drive Longevity Zone 2

Save to Pod

Key Moments

TL;DR

Pain is complex, a sensory and emotional experience shaped by biology, psychology, and social factors. New treatments and understanding help manage chronic pain for better functional recovery.

Key Insights

Pain is a vital evolutionary mechanism, but its subjective nature means physical damage doesn't always correlate with perceived pain.

The Cartesian dualistic model of mind and body is outdated; pain is a biopsychosocial phenomenon, influenced by emotions, cognition, and early life experiences.

Pain signals (nociception) are transmitted via A-delta (sharp, fast) and C fibers (dull, slow), with processing and modulation occurring in the spinal cord and brain.

Chronic pain is a massive societal burden, costing over half a trillion dollars annually, and often requires a multimodal, patient-centric approach.

Pharmacological treatments like NSAIDs, acetaminophen, muscle relaxants, and antidepressants work through various mechanisms, with nuanced applications and side effects.

Novel treatments like low-dose naltrexone (LDN) show promise for refractory pain conditions, potentially by modulating neuroinflammation and central sensitization.

Personalized care, including psychological support, physical rehabilitation, and patient education, is crucial for improving self-efficacy and functional outcomes in chronic pain.

THE BIOLOGICALLY COMPLEX AND EVOLUTIONARY ROLE OF PAIN

Pain is fundamentally an unpleasant sensory and emotional experience, often linked to tissue damage but not always directly. From an evolutionary perspective, pain is a primitive and essential survival mechanism, driving organisms away from danger and promoting self-preservation. Genetic conditions like congenital insensitivity to pain highlight its critical role. Historically, the Cartesian dualistic model separated mind and body, viewing pain as solely a physical sensation perceived by a passive mind. This outdated model, which persisted for centuries, has had detrimental effects on patient care, leading to stigmatization and invalidation, particularly for women with chronic pain. Modern understanding views pain as an integrated biopsychosocial phenomenon, a complex interplay between biological, psychological, and social factors, where the processing of pain signals can be significantly altered by an individual's context and experiences.

UNDERSTANDING NOCICEPTORS AND PAIN SIGNAL TRANSMISSION

Nociceptors are specialized transducers located in skin, soft tissues, deep tissues, and viscera. They convert various forms of energyâ€”pressure, heat, cold, and chemical changes (like pH in infection)â€”into electrochemical impulses (action potentials). These impulses are then transmitted up the nerves through two primary fiber types. A-delta fibers are myelinated, fast-transmitting (10 meters/second), and responsible for sharp, well-localized 'first pain' which triggers immediate withdrawal reflexes at the spinal cord level. C fibers, in contrast, are unmyelinated, slow-transmitting (1 meter/second), and convey a dull, burning, or aching 'second pain' sensation. This slower, more unpleasant pain serves as a longer-term harm alarm, reminding the individual to rest and heal. Pain pathways ascend through the spinal cord, crossing to the contralateral side, primarily via the spinothalamic pathway, before reaching the brain.

THE BRAIN'S ROLE IN PAIN PERCEPTION AND MODULATION

Consciousness is necessary for the experience of pain; while nociceptive signals may be intense during unconsciousness (e.g., surgery), the brain needs to be aware to perceive pain. In the brain, these signals synapse in numerous regions, including the thalamus (acting as a relay station), the anterior cingulate cortex (associated with emotional unpleasantness and salience detection), the insular cortex (integrating emotional and cognitive nuance), and the amygdala (involved in threat detection). The prefrontal cortex plays a crucial role in cognitive control and modulation of pain. The descending control systems originating from the brain can turn down ascending pain signals in the spinal cord. This is partly explained by the gate control theory of pain, where large-diameter A-beta touch fibers can inhibit nociceptive input at the spinal cord level, a phenomenon utilized by TENS units.

TYPES OF PAIN: NOCICEPTIVE, VISCERAL, NEUROPATHIC, AND NOCIPLASTIC

Pain is categorized to aid study and treatment. Nociceptive pain arises from the activation of primary nociceptors due to acute injury; it is typically localized, time-limited, and responsive to common analgesics. Visceral pain originates from nociceptors in internal organs, characterized by diffuse and poorly localized sensations due to convergent pathways in the spinal cord (e.g., shoulder pain during a heart attack). Neuropathic pain results from injury or dysfunction of the peripheral or central nervous system, and patients describe it as burning, sharp, shock-like, or lancinating. It is often challenging to treat with standard analgesics, requiring different drug classes like antineuropathic agents (e.g., gabapentinoids, tricyclic antidepressants). Nociplastic pain is a newly recognized category, referring to pain caused by central pain processing dysfunction in the absence of clear peripheral nociceptive or neuropathic causes, commonly associated with conditions like fibromyalgia.

THE ENIGMA OF FIBROMYALGIA AND ITS MANAGEMENT

Fibromyalgia is a syndrome defined by widespread bodily pain, early morning stiffness, fatigue, mental fog ('fibro fog'), and often gastrointestinal issues. Historically mislabeled and affecting predominantly women, newer definitions are identifying more men. While the exact mechanisms are unknown, research suggests abnormalities in central pain processing and potentially small fiber neuropathy. Fibromyalgia is often preceded by traumatic events, whether physical (e.g., motor vehicle accident) or emotional/sexual abuse, or even infection. Management relies heavily on brain-modulating drugs like tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (e.g., duloxetine), as common analgesics are often ineffective. It's a challenging condition, but management aims to break symptom cycles and improve functional capacity rather than offering a complete cure.

PHARMACOLOGICAL STRATEGIES: NSAIDS, OPIOIDS, AND NEURONTIN

NSAIDs (e.g., ibuprofen, naproxen) inhibit cyclooxygenases, reducing prostaglandins and inflammation. While effective for acute nociceptive pain, long-term use carries risks (cardiac, renal, gastric), and recent data questions whether suppressing inflammation always benefits healing. Acetaminophen's mechanism is still poorly understood but is thought to have central action and synergy with NSAIDs. Muscle relaxants like baclofen are useful for acute muscle spasms, with baclofen being safer for short-term use due to its lack of habit-forming potential. Neurontin (gabapentin) and pregabalin are highly effective for neuropathic pain, working by modulating calcium channels in the spinal cord and brain to dampen pain signals, providing pain relief and enhancing sleep. They are generally safe, with side effects primarily being sedation and some fluid retention. Tricyclic antidepressants (TCAs) are also valuable for neuropathic and chronic pain, modulating serotonin and norepinephrine pathways in the brainstem, not primarily for their antidepressant effects. Opioids are potent analgesics, indispensable in acute care (e.g., post-surgery), but their use in chronic, non-cancer pain is highly nuanced and controversial due to risks of dependence and addiction. Responsible opioid prescribing emphasizes minimizing long-term use and considering patient vulnerabilities like depression or early life trauma.

LOW-DOSE NALTREXONE (LDN): A PROMISING, UNDERSTUDIED THERAPY

Low-dose naltrexone (LDN) is a fascinating off-patent drug showing promise for conditions like fibromyalgia, complex regional pain syndrome, and multiple sclerosis. At 4.5 mg, it is thought to block toll-like 4 receptors on microglia, immune cells in the nervous system that release inflammatory mediators in response to stress or injury. By inhibiting microglial activation and neuroinflammation, LDN may reduce central sensitization and improve pain. LDN is considered very safe due to decades of use at 10x higher doses for opioid and alcohol addiction. Side effects are minimal, mainly vivid dreams and occasional activation. Despite its potential, limited research funding exists due to its off-patent status and regulatory hurdles associated with studying schedule I drugs, hindering definitive understanding of its mechanisms and optimal use.

THE TRANSFORMATIVE POWER OF PATIENT EDUCATION AND SELF-EFFICACY

For individuals suffering from chronic pain, education and fostering self-efficacy are paramount. Understanding their condition, its mechanisms, and the range of available treatments empowers patients to actively participate in their recovery. Learning coping strategies, managing expectations (e.g., realizing that setbacks are not permanent failures), and engaging in physical and psychological rehabilitation are critical for functional improvement. The experience of debilitating pain, although profoundly challenging, can ultimately lead to a deeper understanding of one's body, increased resilience, and an appreciation for health and pain-free movement. This holistic approach, combining medical interventions with patient empowerment, is essential for transforming lives impacted by chronic pain.

Mentioned in This Episode

●Supplements

●Products

●Tools

●Organizations

●Books

●Concepts

●People Referenced

Common Questions

Pain is formally defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. It is a fundamental motivator for survival.

Topics

Nociception Neuropathic Pain Fibromyalgia Opioids Low-Dose Naltrexone (LDN)Acupuncture Brain Imaging Sleep And Pain Mental Health And Pain Anesthesiology

Mentioned in this video

supplementTricyclic Antidepressants (TCAs)

Older antidepressants (like desipramine, nortriptyline, amitriptyline) that are effective for pain management by modulating serotonin and norepinephrine and acting as sodium channel blockers, often used for their pain-relieving properties rather than mood.

conceptA-beta fibers

Wickedly fast touch fibers (100 meters/second) responsible for touch, stroking, and position sense; they act to inhibit nociceptive signals in the spinal cord, a form of neuromodulation.

conceptNociceptors

Specialized transducers in the skin, soft tissues, deep tissues, and viscera that convert different forms of energy (pressure, heat, cold, chemical changes) into electrochemical impulses (action potentials) that are transmitted up nerves.

conceptA-delta fibers

Myelinated nerve fibers (transmitting 10 times faster than C-fibers, about 10 meters/second) that carry a sharp, well-localized jolt of pain, triggering rapid protective reflexes.

toolTENS unit (Transcutaneous Electrical Neural Stimulation)

A medical device that uses electrical stimulation through pads placed over a painful area to activate A-beta fibers, which then inhibit pain signals in the spinal cord.

conceptC-fibers

Thin, slow nerve fibers (transmitting at about 1 meter/second) that carry a hot, burning, flooding sensation of pain, often associated with a longer-term harm alarm.

productVioxx (rofecoxib)

A COX-2 inhibitor that was highly effective for pain but was pulled from the market due to concerns about heart attacks, which both speakers agree was a 'net negative' decision.

supplementBaclofen

A muscle relaxant, considered one of the safest to use and not habit-forming, often used for acute muscle kinks or spasms, and can be delivered intrathecally for intractable spasticity.

supplementOpioids (OxyContin, Fentanyl, Morphine, Dilaudid)

Powerful pain medications, acknowledged to have been overprescribed and abused, but also indispensable tools in pain management, especially in hospital settings and for end-of-life care.

supplementLow-dose naltrexone (LDN)

A fascinating drug with an underground reputation, used at 4.5 milligrams (one-tenth the dose for addiction) to block toll-like four receptors on microglia, reducing neuroinflammation. It has shown magical effects in some patients with conditions like fibromyalgia and complex regional pain syndrome.

organizationBalmar Pharmacy

A compounding pharmacy in Colorado that provides low-dose naltrexone (LDN) at approximately $30 a month, as it cannot be obtained at standard pharmacies.

personAlbert Ellis

A psychologist credited with introducing the concept of catastrophizing in 1962, a term widely used in pain psychology.

supplementPregabalin (Lyrica)

A cousin of gabapentin with the same mechanism of action, often used when gabapentin's dose is maxed out due to its linear kinetic profile, allowing more to enter the system; can also cause drowsiness and water retention.

bookPeter Attia's Book

Peter Attia's book (presumably Outlive: The Science and Art of Longevity) is mentioned as aligning with many factors that predict how well someone manages chronic pain, including self-efficacy, emotional, and cognitive health.

supplementGabapentin (Neurontin)

An anti-seizure medication that is effective for nerve pain, working on calcium channels in the spinal cord and brain to turn down signals; it has no lethal dose but can cause drowsiness and water retention.